1. Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. The emerging problem of nonalcoholic steatohepatitis (NASH).Rom J Gastroenterol 2005;14:43-51.
2. Sanyal AJ. American Gastroenterological AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123(5):1705-1725.
3. Romeo S, Kozlitina J, Xing C. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-1465.
4. He S, McPhaul C, Li JZ. et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2010; 285: 6706-6715.
5. Kumari M, Schoiswohl G, Chitraju C. et al. Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab 2012; 15: 691-702.
6. Dutta AK. A New PCR-RFLP Method for Diagnosing PNPLA3 rs738409 Polymorphism. WebmedCentral GENETICS 2011;2 (11):WMC002401.
7. Калькулятор для расчета статистики в исследованиях "случай-контроль" [http://gen-expert.ru/calculator_or.php].
8. Hernaez R, McLean J, Lazo M. et al. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third national health and nutrition examination survey. Clin Gastroenterol Hepatol. 2013;11:1183–1190.
9. Huang Y, He S, Li JZ. et al. A feed-forward loop amplifies nutritional regulation of PNPLA3// Proc Natl Acad Sci U S A. 2010; 107: 7892–7897.
10. Kitamoto T, Kitamoto A, Yoneda M. et al. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum Genet. 2013;132:783–792.
11.Romeo S, Kozlitina J, Xing C. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease//Nat Genet. 2008;40:1461–1465.m Genet. 2013;132:783–792.
12. Rotman Y, Koh C, Zmuda JM. et al. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease// Hepatology. 2010;52:894–903.
13. Speliotes EK, Butler JL, Palmer CD. et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease// Hepatology. 2010;52:904–912.
14. Devor E.J., Abdurakhmonov I., Zlojutro M. et al. Gene Flow at the Crossroads of Humanity: mtDNA Sequence Diversity and Alu Insertion Polymorphism Frequencies in Uzbekistan// The Open Genomics Journal, 2009; 2: 1-11.
15. Irwin JA, Ikramov A, Saunier J, et al. The mtDNA composition of Uzbekistan: a microcosm of Central Asian patterns. Int J Legal Med 2010, 124: 195–204.
16. Hotta K, Yoneda M, Hyogo H, et al. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med Genet. 2010;11:172.
17. Lin YC, Chang PF, Hu FC, et al. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. J Pediatr. 2011;158:740–744.
18. Romeo S, Sentinelli F, Cambuli VM, et al. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J Hepatol. 2010;53:335–338.
19. Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology. 2011;53:1883–1894.
20. Romeo S, Sentinelli F, Dash S, et al. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes (Lond) 2010;34:190–194.
21. Li JZ, Huang Y, Karaman R, et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J Clin Invest. 2012;122:4130–4144.
22. Valenti L, Rametta R, Ruscica M, et al. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls// BMC Gastroenterol. 2012;12:111.
